stockrowWhat it does
Philip Morris International is a Virginia holding company that sells cigarettes and smoke-free nicotine products to adult smokers and adult users of nicotine-containing products. Its smoke-free portfolio includes heated-tobacco systems, nicotine pouches and e-vapor products. Its principal smoke-free brands are IQOS, ZYN and VEEV. IQOS uses a controlled-heating device and specially designed tobacco units to create an aerosol without combusting tobacco. ZYN includes nicotine pouches, while VEEV is its e-vapor brand. [item1; item7]
The company defines smoke-free products as products that provide nicotine without burning tobacco. It says these products generate lower levels of harmful chemicals and have the potential to present less risk of harm than continued smoking. Smoke-free products were available in 106 markets at December 31, 2025, while its cigarettes were sold in approximately 170 markets. [item1; item7]
Its cigarette portfolio spans premium, mid-price and low-price products and includes international and local brands. Marlboro accounted for approximately 43% of 2025 cigarette shipment volume; Parliament, Chesterfield, L&M and Philip Morris are also international brands. The company is also developing oral consumer wellness offerings through Aspeya, including medical and non-recreational cannabinoid products, although it expects cannabinoid-related revenue to be negligible in the near to medium term. [item1; item7]
Jacek Olczak is Group CEO. [item1]
How it makes money
Philip Morris International earns net revenue by selling products to distributors, wholesalers, retailers, trade partners and consumers. Net revenue includes shipping and handling charged to customers, less sales and promotion incentives and excise taxes. Revenue and operating income depend on product volume, the price charged, product mix, geographic mix and currency movements. [item7]
In FY2025, net revenues were $40.6 billion; in Q3 2026, net revenues were $11.4 billion. Combustible Tobacco Products represented 58.5% of FY2025 revenue, while Smoke-Free Products represented 41.5%. The company reported that FY2025 revenue increased through higher combustible pricing and higher smoke-free volume, despite unfavorable cigarette volume and mix. [item7; product.combustible_tobacco_products.share.fy2025; product.smoke-free_products.share.fy2025]
For 2025 reporting, it operated through Europe, SSEA, CIS & MEA, EA, AU & PMI GTR, and Americas geographic segments. Europe generated $17.1 billion and 42.1% of FY2025 revenue, while SSEA, CIS & MEA generated $12.1 billion and 29.6%. From January 1, 2026, it reorganized into International Smoke-Free, International Combustibles and U.S. reportable segments. [item1; segment.europe.fy2025; segment.europe.share.fy2025; segment.ssea_cis_mea.fy2025; segment.ssea_cis_mea.share.fy2025]
The business has recurring sales because cigarettes, heated-tobacco consumables, nicotine pouches and e-vapor pods are repeatedly bought after initial product adoption. Devices also create device warranty costs. Management said on the Q3 2026 call that pricing was the largest contributor to year-to-date organic revenue growth and that the increasing contribution of smoke-free products added 1.5 points. [item7; call_prepared]
| Product or service | Revenue, FY2025 | Share | Change on the year |
|---|---|---|---|
| Combustible Tobacco Products | $23.8 billion | 58.5% | 2.48% |
| Smoke-Free Products | $16.9 billion | 41.5% | 15.0% |
Customers and how it sells
The company sells through several routes that can operate at the same time in a market: direct sales to retailers; independent distributors; exclusive-territory distributors; national or regional wholesalers; its own e-commerce infrastructure; and its own brand retail infrastructure for smoke-free products and accessories. [item1]
Distributors are important customers in many markets. In 2025, sales to one distributor in Europe and one distributor in EA, AU & PMI GTR each accounted for 10% or more of consolidated net revenue. The company does not consider any business segment dependent on a single customer or small group of customers whose loss would materially harm consolidated results, although losing a distributor can temporarily disrupt a market, particularly in Europe, SSEA, CIS & MEA, and EA, AU & PMI GTR. [item1]
Its 2025 geographic reporting covered Europe; South and Southeast Asia, the Commonwealth of Independent States, Middle East and Africa; East Asia, Australia and global travel retail; and the Americas, which includes the United States, Canada and Latin America. Europe was its largest reported region at $17.1 billion, or 42.1% of FY2025 revenue. [item1; segment.europe.fy2025; segment.europe.share.fy2025]
| Segment | Revenue, FY2025 | Share | Change on the year |
|---|---|---|---|
| Europe | $17.1 billion | 42.1% | 9.06% |
| SSEA, CIS & MEA | $12.1 billion | 29.6% | 7.02% |
| EA, AU & PMI GTR | $6.6 billion | 16.3% | 3.74% |
| Americas | $4.9 billion | 11.9% | 7.06% |
Suppliers and costs
Philip Morris International buys tobacco leaf worldwide, mostly through independent international tobacco suppliers, and also sources directly from farmers in several countries. Direct farmer sourcing represented approximately 23% of its global leaf requirements in 2025. It says world leaf supply is sufficient for its current and anticipated production needs. [item1]
It purchased direct materials from approximately 350 suppliers in 2025. Key materials include packaging board, acetate tow for filters, fine paper, susceptors used in TEREA and other consumables, cloves for Indonesia, and oral-product inputs such as cans, lids, nicotine salt or premix, pouch material and additives. Its ten largest direct-material suppliers represented approximately 60% of direct-material purchases. Electronic devices are made by various electronics manufacturing services providers. [item1]
Cost of sales consists mainly of tobacco leaf, other raw materials, labor and manufacturing, shipping and handling, and third-party-made device costs. Marketing, administration and research costs include selling and marketing, corporate expenses and new-product development. Management said on the Q3 2026 call that energy and shipping costs linked to geopolitical conflict were flowing into input and service costs. [item7; call_qa]
- Revenue$40.6B
- Cost of revenue−$13.4B
- Selling, general and administrative−$12.3B
- Other operating costs−$41.0M
- Operating income$14.9B
Competitive position
Philip Morris International competes on product quality, brand recognition, loyalty, taste, research and development, innovation, packaging, customer service, marketing, advertising and retail price. Its named competitors include Altria Group, British American Tobacco, Japan Tobacco and Imperial Brands, alongside new entrants, regional and local tobacco companies, and some state-owned tobacco enterprises. Competition covers cigarettes and smoke-free nicotine products, including heated tobacco, oral nicotine and e-vapor. [item1]
The company held 29.2% of the total international cigarette and heated-tobacco market in 2025, excluding China and the United States under its definition. Its cigarette share was 23.4% and its heated-tobacco-unit share was 5.8%. Management said on the Q3 2026 call that its international smoke-free portfolio had 62% share of the comparable industry, and that IQOS held approximately 68% adjusted heated-tobacco category share in Japan. [item1; call_prepared]
The company owns or has rights to use its principal trademarks, including Marlboro outside the United States, HEETS, IQOS, IQOS ILUMA, TEREA, VEEV and ZYN. It also has granted patents, pending patent applications, industrial designs, trade secrets, technology and know-how. [item1]
Our reading: Its brands and consumer distribution infrastructure are a strong moat source because they support repeat consumable sales across cigarettes and smoke-free categories in many markets. [item1]
Our reading: Intellectual property is a meaningful moat source, but its protection is limited by competing technologies, regulation and the eight-year settlement arrangement with British American Tobacco concerning certain heat-not-burn and vapor products. [item1]
| Competitor | Where they compete | Threat (our reading) |
|---|---|---|
| Altria Group, Inc. | U.S. cigarettes and smoke-free nicotine products | Medium |
| British American Tobacco plc | International tobacco, heated-tobacco and vapor products | High |
| Japan Tobacco Inc. | International tobacco and heated-tobacco products | High |
| Imperial Brands plc | International tobacco and nicotine products | Medium |
Growth opportunities
The company’s principal growth path is to shift adult nicotine users toward smoke-free products while continuing to generate revenue from combustible tobacco. It has invested over $16 billion since 2008 to develop, scientifically assess and commercialize smoke-free products, with the stated goal of ending cigarette sales. Smoke-free products were available in 106 markets at the end of 2025, and modern oral-pouch presence had reached 56 markets. [item1]
Smoke-Free Products revenue was $16.9 billion in FY2025, representing 41.5% of revenue and growth of 15.0% from FY2024. Management said on the Q3 2026 call that smoke-free shipments increased 2.7% in the quarter, IQOS heated-tobacco-unit shipments reached 41.5 billion units, and VEEV shipments grew 61.6%. It also said new ZYN variants were being distributed in the United States and that major flagship variants were moving from 15-pouch to 20-pouch cans. [product.smoke-free_products.fy2025; product.smoke-free_products.share.fy2025; product.smoke-free_products.yoy.fy2025; call_prepared]
The company is expanding smoke-free categories geographically and by product format. Management said on the call that IQOS showed double-digit growth in markets including Germany, Greece, Spain, Indonesia, the United Kingdom, the Netherlands and global travel retail; it also cited newer growth markets including Mexico, Indonesia and Taiwan. VEEV had been introduced in South Korea, and the company was expanding BONDS by IQOS as an alternative heating proposition. [call_prepared; call_qa]
For 2026, the company expects total shipment growth, organic net-revenue growth of 5% to 7%, organic operating-income growth of 7% to 9%, and adjusted diluted EPS of $8.29 to $8.44. It also expects approximately $13.5 billion of operating cash flow. [call_prepared]
- $31.4BFY2021
- $31.8BFY2022
- $35.2BFY2023
- $37.9BFY2024
- $40.6BFY2025
Structural risks
-
Smoke-free commercialization risk: the company may not successfully introduce, commercialize or grow smoke-free products, and regulators may prohibit or substantially restrict the products or communication of substantiated information and claims. [item1a]
-
Regulation and tax risk: cigarettes and nicotine products face substantial excise taxes, marketing restrictions, packaging requirements, flavor bans, product restrictions, sales restrictions and possible generation sales bans. Tax regimes can alter relative retail prices against competing products. [item1a]
-
International disruption risk: operations in numerous countries expose the company to economic, political, regulatory and currency developments, conflicts, natural disasters and pandemics. The continuation and consequences of the war in Ukraine may adversely affect results, cash flows and financial position. [item1a]
-
Supply-chain and distribution risk: reliance on third-party distributors, manufacturers and service providers can affect product distribution, quality and availability and may require replacement partners. Management said on the Q3 2026 call that Ukraine disruptions and Middle East-related energy and shipping inflation were increasing costs. [item1a; call_prepared]
-
Illicit trade and legal risk: counterfeiting, contraband, cross-border purchases, non-tax-paid volume and other non-compliant products may reduce revenue. Litigation related to tobacco and nicotine products could reduce profitability and impair liquidity. [item1a]
-
Technology and transaction risk: the company depends significantly on its own and third-party information-technology networks and systems, and a cybersecurity incident could affect operations. It may also fail to identify, complete or realize benefits from acquisitions, divestitures, joint ventures or investments. [item1a]
Bottom line
Our reading
Our reading: Philip Morris International is a global nicotine-products business in which recurring consumable sales from cigarettes, heated-tobacco units, nicotine pouches and e-vapor products are central to revenue generation. [item1; item7]
Our reading: Its transition rests on building IQOS, ZYN and VEEV while retaining combustible pricing and distribution economics; smoke-free products represented 41.5% of FY2025 revenue. [item1; product.smoke-free_products.share.fy2025]
Our reading: The main constraints are regulation, taxation, illicit trade, litigation, conflict-related disruption and the execution required to convert adult users to smoke-free products. [item1a; call_prepared]